[1]尹静华.核黄素磷酸钠联合干扰素治疗小儿疱疹性咽峡炎的 疗效观察[J].医学信息,2018,31(10):138-139,142.[doi:10.3969/j.issn.1006-1959.2018.10.046]
　YIN Jing-hua.Therapeutic Effect of Riboflavin Sodium Phosphate Combined with Interferon on Pediatric Herpangina[J].Journal of Medical Information,2018,31(10):138-139,142.[doi:10.3969/j.issn.1006-1959.2018.10.046]
点击复制

核黄素磷酸钠联合干扰素治疗小儿疱疹性咽峡炎的 疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年10期
页码:
138-139,142
栏目:
药物与临床
出版日期:
2018-05-15

文章信息/Info

Title:
Therapeutic Effect of Riboflavin Sodium Phosphate Combined with Interferon on Pediatric Herpangina
文章编号:
1006-1959（2018）10-0138-03
作者:
尹静华
重庆市丰都县中医院儿科，重庆 408200
Author(s):
YIN Jing-hua
Department of Pediatrics,Fengdu Traditional Chinese Medicine Hospital,Chongqing 408200,China
关键词:
核黄素磷酸钠; 干扰素; 疱疹性咽峡炎
Keywords:
Key words：Riboflavin sodium phosphate; Interferon; Herpetic angina
分类号:
R766.12
DOI:
10.3969/j.issn.1006-1959.2018.10.046
文献标志码:
A
摘要:
目的 观察核黄素磷酸钠联合干扰素治疗小儿疱疹性咽峡炎的临床疗效。方法 选取2016年5月~2017年10月在我院治疗的72例小儿疱疹性咽峡炎患儿临床资料为研究对象，将其随机分为对照组和观察组，每组36例。对照组采用干扰素治疗，观察组在对照组基础上联合应用核黄素磷酸钠治疗，对比两组患者治疗总有效率、体征平均消退时间、住院时间和不良反应情况。结果 观察组治疗有效率为91.67%，高于对照组的77.78%，差异具有统计学意义（P＜0.05）；观察组患儿体征平均消退时间为（2.88±1.20）d，住院时间为（5.87±1.66）d，分别短于对照组的（3.14±1.11）d，（7.53±0.95）d，差异有统计学意义（P＜0.05）；观察组不良反应发生率为8.33%，低于对照组的22.22%，差异有统计学意义（P＜0.05）。结论 核黄素磷酸钠联合干扰素治疗小儿疱疹性咽峡炎可快速改善患儿临床症状，且临床不良反应少，具有临床应用和推广的重要价值。
Abstract:
Abstract：Objective To observe the clinical efficacy of riboflavin sodium phosphate combined with interferon in the treatment of pediatric herpangina.Methods The clinical data of 72 children with herpes isthmus treated in our hospital from May 2016 to October 2017 were randomly divided into control group(n=36)and observation group(n=36).The control group was treated with interferon,the observation group was treated with riboflavin sodium phosphate on the basis of the control group,and the total effective rate,mean regression time of signs,hospitalization time and adverse reactions were compared between the two groups.Results The effective rate was 91.67% in the observation group,which was 77.78% higher than that in the control group,the difference was statistically significant(P<0.05).The mean extinction time of the observation group was (2.88±1.20)d,and the length of hospital stay was(5.87±1.66) d,which was shorter than that of the control group (3.14±1.11)d,(7.53±0.95)d,the difference was statistically significant(P<0.05);the incidence of adverse reactions in the observation group was 8.33%,which was lower than the 22.22% of the control group,and the difference was statistically significant(P<0.05).Conclusion The combination of riboflavin sodium phosphate and interferon in the treatment of pediatric herpangina can rapidly improve the clinical symptoms of children,and there are few clinical adverse reactions.It has important clinical application and promotion value.

参考文献/References:

[1]牛伟红,杨丽萍,秦明月,等.核黄素磷酸钠联合热毒宁注射液治疗疱疹性咽峡炎疗效分析[J].河北医科大学学报,2014,35(02):199-201.
[2]陈丹,何肇睛.核黄素磷酸钠治疗多西他赛化疗后口腔溃疡的疗效分析[J].实用临床医药杂志,2013,17(21):131-136.
[3]薛慧敏,魏洪伟,李国庆,等.干扰素不同用药途径治疗小儿疱疹性咽峡炎疗效观察[J].中外医疗,2012,16(4):18-19.
[4]黄蓉.核黄素磷酸钠联合干扰素治疗小儿疱疹性咽峡炎的疗效观察[J].现代药物与临床,2016,31(2):186-189.
[5]杨丽萍,王敬君.核黄素磷酸钠联合干扰素α1b治疗疱疹性咽峡炎的临床观察[J].海南医学,2016,27(6):1005-1006.
[6]钟秋兰,郑亚文,严建佳,等.干扰素雾化与利巴韦林治疗婴幼儿疱疹性咽峡炎的临床疗效与安全性对比观察[J].中国医药科学,2017,7(3):80-82.
[7]任麦青.两种方案治疗小儿疱疹性咽峡炎疗效比较[J].医学信息,2014,27(9):353.
[8]袁玉肖,姜凯,马占敏.热毒宁注射液联合α-干扰素治疗疱疹性咽峡炎临床观察[J].新乡医学院学报,2014,31(5):403-404.
[9]江煜.蒲地蓝消炎口服液联合干扰素治疗小儿疱疹性咽峡炎疗效观察[J].浙江中西医结合杂志,2012,22(7):550-551.
[10]石聪聪.阿糖腺苷联合核黄素磷酸钠治疗疱疹性咽峡炎疗效观察[J].中国实用医药,2017,12(11):116-117.

相似文献/References:

[1]汪晓凤,邵和军.慢性乙型肝炎抗病毒治疗进展[J].医学信息,2019,32(04):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
　WANG Xiao-feng,SHAO He-jun.Progress in Antiviral Therapy for Chronic Hepatitis B[J].Journal of Medical Information,2019,32(10):39.[doi:10.3969/j.issn.1006-1959.2019.04.015]
[2]唐奇远,吴晓娟,赖晓娟,等.Peg-IFNa-2b单药与联合NAs治疗HBeAg阳性慢乙肝初治患者的疗效比较[J].医学信息,2022,35(08):115.[doi:10.3969/j.issn.1006-1959.2022.08.028]
　TANG Qi-yuan,WU Xiao-juan,LAI Xiao-juan,et al.Comparison of the Efficacy on Peg-IFNa-2b Monotherapy and NAs Combined Therapy in Patients with HBeAg Positive Chronic Hepatitis B[J].Journal of Medical Information,2022,35(10):115.[doi:10.3969/j.issn.1006-1959.2022.08.028]
[3]郭钊宏,邱友军,张 慧,等.干扰素雾化吸入联合阿昔洛韦口服治疗小儿疱疹性咽峡炎的临床疗效[J].医学信息,2023,36(15):136.[doi:10.3969/j.issn.1006-1959.2023.15.028]
　GUO Zhao-hong,QIU You-jun,ZHANG Hui,et al.Clinical Efficacy of Interferon Atomization Inhalation Combined with Acyclovir Orally in the Treatment of Children with Herpetic Angina[J].Journal of Medical Information,2023,36(10):136.[doi:10.3969/j.issn.1006-1959.2023.15.028]
[4]谭子跃.干扰素合并恩替卡韦治疗乙型病毒性肝炎患者的疗效及对患者肝功能的影响[J].医学信息,2023,36(20):137.[doi:10.3969/j.issn.1006-1959.2023.20.027]
　TAN Zi-yue.Effect of Interferon Combined with Entecavir in the Treatment of Patients with Hepatitis B and its Effect on Liver Function[J].Journal of Medical Information,2023,36(10):137.[doi:10.3969/j.issn.1006-1959.2023.20.027]

更新日期/Last Update: 2018-05-15